polyclonally expanded Tregs (polyTregs)
Showing 1 - 25 of 1,649
Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant Trial in United States (biological, drug,
Recruiting
- Kidney Transplant
- +3 more
- Polyclonal Regulatory T Cells
- +10 more
-
Birmingham, Alabama
- +5 more
Feb 22, 2022
Pemphigus Foliaceus, Pemphigus Vulgaris Trial in United States (Cohort 1: 1.0 x 10^8 PolyTregs, Cohort 2: 2.5x10^8 PolyTregs)
Active, not recruiting
- Pemphigus Foliaceus
- Pemphigus Vulgaris
- Cohort 1: 1.0 x 10^8 PolyTregs
- Cohort 2: 2.5x10^8 PolyTregs
-
San Francisco, California
- +3 more
Oct 22, 2021
Type 1 Diabetes Trial in San Francisco, New Haven (PolyTregs+IL-2)
Completed
- Type 1 Diabetes Mellitus
- PolyTregs+IL-2
-
San Francisco, California
- +1 more
Oct 15, 2021
Diabetes type1 Trial (cePolytreg)
Not yet recruiting
- Diabetes type1
- cePolytreg
- (no location specified)
Jul 8, 2022
Aplastic Anemia Trial in London (Expanded autologous T regulatory cells)
Recruiting
- Aplastic Anemia
- Expanded autologous T regulatory cells
-
London, United KingdomKing's College Hospital
Aug 16, 2022
GVHD Trial in Tampa (Cultured Treg cells)
Completed
- Graft Versus Host Disease
- Cultured Treg cells
-
Tampa, FloridaH Lee Moffitt Cancer Center
Nov 2, 2022
Late Complication From Kidney Transplant Trial in San Francisco (Treg infusion)
Completed
- Late Complication From Kidney Transplant
- Treg infusion
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 11, 2022
Allergic Rhinoconjunctivitis to Birch Pollen, With a Positive Skin Prick Test to Birch Pollen Trial in Paris (ILT-101 ld-(IL2))
Completed
- Allergic Rhinoconjunctivitis to Birch Pollen
- With a Positive Skin Prick Test to Birch Pollen
- ILT-101 ld-(IL2)
-
Paris, FranceCIC Paris Est GH Pitié Salpétrière
Dec 13, 2022
ALS (Amyotrophic Lateral Sclerosis) Trial in Boston, Houston (Monthly autologous Treg cells infusions + 3 times per week
Active, not recruiting
- ALS (Amyotrophic Lateral Sclerosis)
- Monthly autologous Treg cells infusions + 3 times per week Interleukin-2 injections
- Monthly placebo infusions + 3 times per week placebo injections
-
Boston, Massachusetts
- +1 more
Sep 29, 2021
Rheumatoid Arthritis, Swelling Joint, Joint Fluid Trial in Montpellier (Exploratory synovial fluid analysis)
Recruiting
- Rheumatoid Arthritis
- +3 more
- Exploratory synovial fluid analysis
-
Montpellier, FranceLapeyronie Hospital
Jan 12, 2022
Type 1 Diabetes Trial in Worldwide (rhIL-2, Placebo)
Active, not recruiting
- Type 1 Diabetes
- rhIL-2
- Placebo
-
Liège, Province De Liège, Belgium
- +33 more
Feb 9, 2022
Alzheimer Trial in Houston (Interleukin-2, Placebo)
Recruiting
- Alzheimer Disease
- Interleukin-2
- Placebo
-
Houston, TexasHouston Methodist Research Institute
Oct 17, 2023
Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor, Refractory Sclerodermatous GVHD Trial in Duarte (procedure,
Not yet recruiting
- Hematopoietic and Lymphoid System Neoplasm
- +2 more
- Biospecimen Collection
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 23, 2022
Liver Transplant Trial in Boston (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg-CSB
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital: Transplantation
Jan 30, 2023
Tregs CD25 CXCL9 in Vitiligo
Not yet recruiting
- Vitiligo
- +3 more
- ELIZA , Flowcytometry
- (no location specified)
Oct 3, 2022
Microparticle Delivered STING Agonist in Control of Experimental
Recruiting
- Relapse Remitting Multiple Sclerosis
- Blood Draw
-
Philadelphia, PennsylvaniaThomas Jefferson University
Jan 20, 2023
Heart Failure, Systolic Trial (CardiALLO™ Human Allogenic Culture-expanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs))
Not yet recruiting
- Heart Failure, Systolic
- CardiALLO™ Human Allogenic Culture-expanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs)
- (no location specified)
Jun 22, 2023
Liver Transplant Trial in San Francisco (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 13, 2022
Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute
Recruiting
- Acute Rejection of Renal Transplant
- Graft Failure
- Donor-derived cell-free DNA
-
Loma Linda, CaliforniaLoma Linda University Health
Jul 19, 2022